Want to see ECIA full AI Analyst Report?
Encision (ECIA) Stock Price & Analysis
ECIA Stock Chart & Stats
- Day’s Range
- $0.01 - $0.04
- 52-Week Range
- $0.01 - $0.25
- Previous Close
- $0.01
- Volume
- 5,100
- Average Volume (3M)
- 2,647
- Market Cap
- $194.12K
- Enterprise Value
- $1.34M
- Total Cash (Recent Filing)
- $275.43K
- Total Debt (Recent Filing)
- $1.42M
- Price to Earnings (P/E)
- ―
- Beta
- 25.58
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Solid Gross Margin
A gross margin near 47% indicates the company continues to retain meaningful value from its products despite declining revenue. This provides an underlying base for improvement if management can align operating expenses with the current revenue scale over the next several quarters.
Positive Equity Base
Positive shareholders’ equity and relatively stable total assets provide some balance-sheet substance despite worsening leverage and losses. This financial base may preserve flexibility compared with a company already operating with negative equity, although profitability remains a significant constraint.
Meaningful Gross Profit
Meaningful gross profit shows that the core products still generate value after direct costs, even though the overall business is loss-making. That foundation could support a return toward sustainability if revenue stabilizes and the cost structure becomes more proportionate.
Bears Say
Declining Revenue
Several years of shrinking revenue, including another decline of about 8%, indicate weakening commercial scale rather than a temporary fluctuation. Continued contraction can reduce operating leverage, limit investment capacity, and make it harder for the company to absorb fixed costs.
Persistent Losses
Negative operating and net margins show that the current revenue base does not cover the company’s full cost structure. This weakens internal funding capacity and makes sustained improvement dependent on reversing revenue pressure or reducing expenses without damaging product economics.
Negative Cash Generation
Negative operating and free cash flow mean the business is not self-funding today, despite retaining meaningful gross profit. Continued cash outflows can increase reliance on financing or balance-sheet flexibility and reduce the resources available for product development and growth.
Encision News
ECIA FAQ
What was Encision’s price range in the past 12 months?
What is Encision’s market cap?
When is Encision’s upcoming earnings report date?
How were Encision’s earnings last quarter?
Is Encision overvalued?
Does Encision pay dividends?
What is Encision’s EPS estimate?
How many shares outstanding does Encision have?
What happened to Encision’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Encision?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Encision
Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Robert H. Fries
- Employees
- 23
- Website
- www.encision.com
- Address
- 6797 Winchester Circle, Boulder, CO, 80301, US
Encision (ECIA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 1 | 12 |
| Technical Analysis | 5 | 1 | 2 |
| Moving Averages | 2 | 0 | 10 |







